Latest news with #TheWoodlands
Globe and Mail
a day ago
- Business
- Globe and Mail
Autonomix Medical, Inc. Participates in the Virtual Investor 'What's Your Story' Summer Spotlight On-Demand Conference
– Video webcast now available on-demand THE WOODLANDS, TX, July 22, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) ('Autonomix' or the 'Company'), a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated, today announced that Brad Hauser, Chief Executive Officer of Autonomix, participated in the Virtual Investor 'What's Your Story' Summer Spotlight On-Demand Conference. For the event, Mr. Hauser dove deeper into his dedication to the Company, how he got to where he is today, and provided insight into why he is passionate about the Company's innovative technology. The on-demand video webcast is now available on the Virtual Investor website as well as the Events page under the Investors section of the Company's website ( About Autonomix Medical, Inc. Autonomix is a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated. The Company's first-in-class platform system technology includes a catheter-based microchip sensing array that may have the ability to detect and differentiate neural signals with greater sensitivity than currently available technologies. We believe this will enable, for the first time ever, transvascular diagnosis and treatment of diseases involving the peripheral nervous system virtually anywhere in the body. We are initially developing this technology for the treatment of pain, with initial trials focused on pancreatic cancer, a condition that causes debilitating pain and is without a reliable solution. Our technology constitutes a platform to address dozens of potential indications, including cardiology, hypertension and chronic pain management, across a wide disease spectrum. Our technology is investigational and has not yet been cleared for marketing in the United States. For more information, visit and connect with the Company on X, LinkedIn, Instagram and Facebook. Investor and Media Contact JTC Team, LLC Jenene Thomas 908.824.0775 autonomix@ This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
Yahoo
a day ago
- Business
- Yahoo
Autonomix Medical, Inc. Participates in the Virtual Investor 'What's Your Story' Summer Spotlight On-Demand Conference
– Video webcast now available on-demand THE WOODLANDS, TX, July 22, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) ('Autonomix' or the 'Company'), a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated, today announced that Brad Hauser, Chief Executive Officer of Autonomix, participated in the Virtual Investor 'What's Your Story' Summer Spotlight On-Demand Conference. For the event, Mr. Hauser dove deeper into his dedication to the Company, how he got to where he is today, and provided insight into why he is passionate about the Company's innovative technology. The on-demand video webcast is now available on the Virtual Investor website as well as the Events page under the Investors section of the Company's website ( About Autonomix Medical, Inc. Autonomix is a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated. The Company's first-in-class platform system technology includes a catheter-based microchip sensing array that may have the ability to detect and differentiate neural signals with greater sensitivity than currently available technologies. We believe this will enable, for the first time ever, transvascular diagnosis and treatment of diseases involving the peripheral nervous system virtually anywhere in the body. We are initially developing this technology for the treatment of pain, with initial trials focused on pancreatic cancer, a condition that causes debilitating pain and is without a reliable solution. Our technology constitutes a platform to address dozens of potential indications, including cardiology, hypertension and chronic pain management, across a wide disease spectrum. Our technology is investigational and has not yet been cleared for marketing in the United States. For more information, visit and connect with the Company on X, LinkedIn, Instagram and Facebook. Investor and Media ContactJTC Team, LLCJenene Thomas908.824.0775autonomix@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Globe and Mail
2 days ago
- Business
- Globe and Mail
TWFG Insurance to release its second quarter financial results on August 12th, 2025
THE WOODLANDS, Texas, July 21, 2025 (GLOBE NEWSWIRE) -- TWFG, Inc. (NASDAQ: TWFG), a leading independent insurance distribution platform, announced today that it will release its financial results for the second quarter ended June 30, 2025, after the market closes on Tuesday, August 12, 2025. The Company will host a conference call to discuss its financial results the following morning, Wednesday, August 13, 2025, at 9:00 a.m. Central Time (10:00 a.m. Eastern Time). TO ACCESS THE CALL BY PHONE, PARTICIPANTS CAN REGISTER AT THIS LINK WHERE THEY WILL BE PROVIDED WITH THE DIAL IN DETAILS. A live webcast of the call will be available on TWFG's Investor Relations website at Interested parties are encouraged to register and access the webcast at least 10 minutes prior to the scheduled start time. A replay of the webcast will be available on the Investor Relations website for a limited time following the call. About TWFG TWFG, Inc. (NASDAQ: TWFG) is a leading insurance distribution platform providing innovative and personalized insurance solutions to individuals and businesses across the United States. Founded with a commitment to service, professionalism, and entrepreneurial spirit, TWFG empowers its extensive network of agents to deliver client-focused insurance options across a broad array of personal and commercial lines. For more information, please visit Investor Contact: Gene Padgett TWFG, Inc. - Chief Accounting Officer Email: PR Contact: Alex Bunch TWFG, Inc. – CMO E-mail: alex@
Globe and Mail
7 days ago
- Business
- Globe and Mail
Ring Energy Announces Timing of Second Quarter 2025 Earnings Release and Conference Call
THE WOODLANDS, Texas, July 16, 2025 (GLOBE NEWSWIRE) -- Ring Energy, Inc. (NYSE American: REI) ('Ring' or the 'Company') today announced the timing of its second quarter 2025 earnings release and conference call. Ring plans to issue its second quarter 2025 earnings release after the close of trading on Wednesday, August 6, 2025. The Company has scheduled a conference call on Thursday, August 7, 2025 at 11:00 a.m. ET (10:00 a.m. CT) to discuss its second quarter operational and financial results. To participate, interested parties should dial 833-953-2433 at least five minutes before the call is to begin. Please reference the 'Ring Energy Earnings Conference Call'. International callers may participate by dialing 412-317-5762. The call will also be webcast and available on Ring's website at under 'Investors' on the 'News & Events' page. An audio replay will also be available on the Company's website following the call. About Ring Energy, Inc. Ring Energy, Inc. is an oil and gas exploration, development, and production company with current operations focused on the development of its Permian Basin assets. For additional information, please visit Contact Information
Yahoo
16-07-2025
- Business
- Yahoo
Draup Launches Curie: The Agentic AI Built for Enterprise HR Teams
THE WOODLANDS, Texas, July 16, 2025 /CNW/ -- Draup, the leader in enterprise talent intelligence, today announced the launch of Curie: a purpose-built agentic AI product that radically redefines how HR leaders turn complex labor and market data into strategic decisions. As enterprises navigate global talent shortages, rapid skill evolution, and rising pressure to future-proof their workforce, Curie steps in to close the gap between data overload and actionable talent decisions. "Curie is a GenAI Assistant purpose-built to combine Draup's powerful labor market data with the simplicity of natural conversation. From workforce planning and talent acquisition to skills architecture, Curie delivers instant, actionable insights that previously took weeks to generate. As a strategic digital twin, Curie empowers HR to shape the future of work with unprecedented speed and clarity. One of the most rewarding moments was when a senior HR leader shared that they used Curie to create a comprehensive white paper on location strategy for their CHRO—in under two hours." — Vijay Swaminathan, CEO & Co-Founder, Draup Built on one of the world's richest labor and market datasets spanning 1.5 million companies, 18,000 skills, 850 million professionals, and 4 million career paths, Curie makes workforce planning radically faster, smarter, and easier. Talent teams can use Curie to explore emerging skills across domains like AI and cybersecurity, assess the best global locations to hire specific talent, and identify redundant roles. They can also evaluate reskilling paths for impacted employees, compare compensation benchmarks across geographies, and understand how to evolve their talent architecture to align with business transformation. A New Kind of AI for HR: Agentic, Not Just Assistive Unlike conventional AI assistants, Curie is agentic. It is designed to take initiative, understand context, and navigate vast, interconnected data to deliver decision-ready insights. "Most business and HR leaders recognize the critical role of workforce planning in enabling business performance. Yet, organizations often struggle to execute it effectively. Curie by Draup is one of the most promising solutions for closing this gap — unlocking the power of agentic AI and labor market data for faster, more informed talent decisions that drive business results." — Brian Heger, Founder of Talent Edge Weekly Curie allows users to: Uncover skill gaps, forecast demand, and align workforce transformation Identify emerging roles, design reskilling paths, and stay ahead of talent shifts Benchmark compensation trends, identify strategic whitespace, and model location strategies And more Ready to Meet Curie: Book a demo to experience how Draup's agentic AI can reshape the way enterprises make decisions. About Draup Draup is a Talent Strategy Platform that equips HR leaders with real-time labor and market data to power workforce planning, recruitment, and skills transformation. By offering deep insights into global talent, peer benchmarks, and career pathing, Draup helps organizations design future-ready workforce strategies with precision and confidence. For media inquiries, please contact: Shyam RavishankarHead of Marketing Logo: View original content: SOURCE Draup View original content: Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
